Phase II
A Phase 2, Global, Multicenter, Long-term Safety Study Designed to Assess the Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy
- Study HIC#:2000040744
- Last Updated:03/24/2026
- Age18 years - 75 years
- GenderBoth
Contact Us
For more information about this study, including how to volunteer, contact:
Danielle Carlson
- Phone Number: 1-203-785-2253
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
